{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:10:14Z","timestamp":1789017014583,"version":"build-2803163510"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>DOCK8 deficiency is a severe autosomal recessive combined immunodeficiency characterized by recurrent infections, severe atopy, immune dysregulation, and an increased risk of malignancy. Allogeneic hematopoietic stem cell transplantation (HSCT) remains the only curative treatment. We aimed to evaluate the long-term survival, immune reconstitution, and clinical outcomes of patients with DOCK8 deficiency following HSCT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective single-center study of 47 patients with genetically confirmed DOCK8 deficiency who underwent HSCT at King Faisal Specialist Hospital and Research Centre between 2012 and 2025. Clinical, immunologic, genetic, transplant-related, and survival outcomes were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Eczema was present in all patients, while 91.5% had food allergies and 55% had recurrent sinopulmonary infections. Pre-transplant malignancy was identified in 17% of patients. Genetic analysis revealed predominantly homozygous loss-of-function variants. HSCT was performed at a median age of 6 years, using matched related donors in 37\/47 patients (79%), matched unrelated donors in 7\/47 (15%), haploidentical donors in 2\/47 (4%), and an umbilical cord blood graft in 1\/47 (2%). After a median follow-up of 7 years, overall survival and event-free survival were both 91.5%. Survival was 94.6% following matched related donor transplantation and 100% following matched unrelated donor transplantation. Mortality was limited to the early post-transplant period and was primarily associated with pre-existing malignancy or irreversible organ damage. All survivors demonstrated complete resolution of eczema and recurrent infections and robust immune reconstitution.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>HSCT provides excellent long-term survival and durable immune correction in patients with DOCK8 deficiency. Early diagnosis and transplantation before the development of irreversible organ damage are critical determinants of favorable outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1930996","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:31:21Z","timestamp":1789014681000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Hematopoietic stem cell transplantation for DOCK8 deficiency: durable immune reconstitution and long-term survival in 47 patients"],"prefix":"10.3389","volume":"17","author":[{"given":"Bashayr","family":"Alanazi","sequence":"first","affiliation":[{"name":"Section of Pediatric Allergy and Immunology, Department of Pediatrics, King Faisal Specialist Hospital and Research Centre","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem","family":"Mohammed","sequence":"additional","affiliation":[{"name":"Section of Pediatric Allergy and Immunology, Department of Pediatrics, King Faisal Specialist Hospital and Research Centre","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Al-Ahmari","sequence":"additional","affiliation":[{"name":"Section of Stem Cell Transplantation, Department of Pediatric Hematology\/Oncology, King Faisal Specialist Hospital and Research Centre","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Alrumayan","sequence":"additional","affiliation":[{"name":"Section of Pediatric Allergy and Immunology, Department of Pediatrics, King Faisal Specialist Hospital and Research Centre","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hawazen","family":"Alsaedi","sequence":"additional","affiliation":[{"name":"Section of Stem Cell Transplantation, Department of Pediatric Hematology\/Oncology, King Faisal Specialist Hospital and Research Centre","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouhab","family":"Ayas","sequence":"additional","affiliation":[{"name":"Section of Stem Cell Transplantation, Department of Pediatric Hematology\/Oncology, King Faisal Specialist Hospital and Research Centre","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sultan","family":"Albuhairi","sequence":"additional","affiliation":[{"name":"Section of Pediatric Allergy and Immunology, Department of Pediatrics, King Faisal Specialist Hospital and Research Centre","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Elshorbagi","sequence":"additional","affiliation":[{"name":"Section of Pediatric Allergy and Immunology, Department of Pediatrics, King Faisal Specialist Hospital and Research Centre","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rand","family":"Arnaout","sequence":"additional","affiliation":[{"name":"Section of Pediatric Allergy and Immunology, Department of Pediatrics, King Faisal Specialist Hospital and Research Centre","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anas M.","family":"Alazami","sequence":"additional","affiliation":[{"name":"Department of Translational Genomics, Genomic Medicine Centre of Excellence, King Faisal Specialist Hospital and Research Center","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bandar","family":"AlSaud","sequence":"additional","affiliation":[{"name":"Section of Pediatric Allergy and Immunology, Department of Pediatrics, King Faisal Specialist Hospital and Research Centre","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamoud","family":"Al-Mousa","sequence":"additional","affiliation":[{"name":"Section of Pediatric Allergy and Immunology, Department of Pediatrics, King Faisal Specialist Hospital and Research Centre","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.10.038","article-title":"Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome","volume":"124","author":"Engelhardt","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa0905506","article-title":"Combined immunodeficiency associated with DOCK8 mutations","volume":"361","author":"Zhang","year":"2009","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-014-0126-0","article-title":"DOCK8 deficiency: Clinical and immunological phenotype and treatment options - a review of 136 patients","volume":"35","author":"Aydin","year":"2015","journal-title":"J ClinImmunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.12.1945","article-title":"The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency","volume":"136","author":"Engelhardt","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10875-012-9769-x","article-title":"Clinical, immunological and molecular characterization of DOCK8 and DOCK8-like deficient patients: single center experience of twenty-five patients","volume":"33","author":"Alsum","year":"2013","journal-title":"J ClinImmunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/imr.12723","article-title":"Insights into immunity from clinical and basic science studies of DOCK8 immunodeficiency syndrome","volume":"287","author":"Su","year":"2019","journal-title":"Immunol Rev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20110345","article-title":"DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice","volume":"208","author":"Randall","year":"2011","journal-title":"J Exp Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.2075oia223","article-title":"DOCK8 regulates lymphocyte shape integrity for skin antiviral immunity","volume":"211","author":"Zhang","year":"2014","journal-title":"J Exp Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/aci.0000000000001115","article-title":"DOCK8 deficiency","volume":"25","author":"Gennery","year":"2025","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00295","article-title":"Hematopoietic stem cell transplantation in primary immunodeficiency diseases: Current status and future perspectives","volume":"7","author":"Castagnoli","year":"2019","journal-title":"Front Pediatr"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2018.10.035","article-title":"Hematopoietic stem cell transplantation as treatment for patients with DOCK8 deficiency","volume":"7","author":"Aydin","year":"2019","journal-title":"J Allergy Clin Immunol In Pract"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2024.08.021","article-title":"Hematopoietic cell transplantation for DOCK8 deficiency: Results from a prospective clinical trial","volume":"155","author":"Freeman","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.127527","article-title":"Hematopoietic stem cell transplant effectively rescues lymphocyte differentiation and function in DOCK8-deficient patients","volume":"5","author":"Pillay","year":"2019","journal-title":"JCI Insight"},{"key":"B14","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.ajhg.2019.09.019","article-title":"Lessons learned from large-scale, first-tier clinical exome sequencing in a highly consanguineous population","volume":"105","author":"Monies","year":"2019","journal-title":"Am J Hum Genet"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.12.1310","article-title":"Unbiased targeted next-generation sequencing molecular approach for primary immunodeficiency diseases","volume":"137","author":"Al-Mousa","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B16","article-title":"1994 consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"B17","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplantation: J Am Soc For Blood Marrow Transplant"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2003.07.003","article-title":"Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study","volume":"112","author":"Shearer","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.11.017","article-title":"Food allergies can persist after myeloablative hematopoietic stem cell transplantation in dedicator of cytokinesis 8-deficient patients","volume":"137","author":"Happel","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2010.02.003","article-title":"Gene therapy for immunodeficiency due to adenosine deaminase deficiency","volume":"360","author":"Aiuti","year":"2009","journal-title":"N Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1003548","article-title":"Stem-cell gene therapy for the Wiskott-Aldrich syndrome","volume":"363","author":"Boztug","year":"2010","journal-title":"N Engl J Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fgeed.2022.793010","article-title":"CRISPR\/Cas-based gene editing strategies for DOCK8 immunodeficiency syndrome","volume":"4","author":"Ravendran","year":"2022","journal-title":"Front Genome Ed"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1930996\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:31:30Z","timestamp":1789014690000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1930996\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":22,"alternative-id":["10.3389\/fimmu.2026.1930996"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1930996","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"article-number":"1930996"}}